Proteomics International - Biosimilars, Biomarkers & Therapeutics
Founded 2001 Listed on ASX April 2015 - Proteomics International Laboratories Ltd (PILL, ASX: PIQ) Proteomics International is a medical technology company focused on proteomics – the industrial-scale study of the structure and function of proteins. Proteomics International has over 16 years of experience in providing specialist analytical services on a fee-for-service basis . The strength of the company’s research expertise in finding new diagnostic protein biomarkers has also resulted in a ground-breaking predictive test for diabetic kidney disease – PromarkerD.